| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Sep―06 |
A case of a geriatric patient with thrombocytopenia after partial recovery from COVID-19 |
Yukako Hayashi, Kenji Momo, Mutsumi Ando, Hiroaki Koya, Tsutomu Nagai, Kazuki Shinmura, et al. (+3) Issei Tokimatsu, Yasushi Akutsu, Masahiro Kurosawa |
| 2 |
[GO] |
2024―Jun―26 |
Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use |
Nursel Sürmelioğlu, Esra Demirtürk, Nazire Ateş Ayhan, Aysun Özel Yeşilyurt, Sinem Bayrakçi, Mustafa Sinan Kaynak, et al. (+2) Ezgi Özyılmaz, Karel Allegaert |
| 3 |
[GO] |
2024―Mrz―12 |
Efficacy and safety of antiplatelet therapy in COVID-19: Insights from a meta-analysis of randomized controlled trials |
Guoying Kao, Yunlin Chen, Jinqi Fan |
| 4 |
[GO] |
2024―Mrz―03 |
Low albumin combined with low-molecular-weight heparin as risk factors for liver injury using azvudine: Evidence from an analysis of COVID-19 patients in a national prospective pharmacovigilance database |
Hong Lu, Ying Zeng, Qun-Zhi Shi, Lin Liu, Yong-Qing Gong, Sen Li, Pan Yan |
| 5 |
[GO] |
2024―Jan―04 |
Hoarding of insulin and oral antidiabetics in the first phase of the COVID-19 pandemic: Regulatory actions taken to avoid shortage |
Björn Zethelius, Anders Sundström, Kenneth Nordback, Karl-Mikael Kälkner, Rickard Ljung |
| 6 |
[GO] |
2023―Nov―09 |
Leukopenia associated with lamotrigine initiation after COVID-19 vaccine booster: A case report and literature review |
Tsukasa Murata, Katsuaki Uno, Miki Ito, Takahiko Nagamine |
| 7 |
[GO] |
2023―Okt―25 |
Potential drug-drug interactions in a multi-center study of death cases of COVID-19: The significance of appropriate drug choice |
Ayda Esmaeili, Zahra Niazkhani, Khadijeh Makhdoomi, Iraj Mohebbi, Javad Aghazadeh-Attari, Ebrahim Hassani, et al. (+8) Seyed Jalil Mousavi, Naser Gharebaghi, Rahim Nejadrahim, Mohammad Mirza-Aghzadeh, Aysan Esmaeili, Mojgan Cheshmekaboodi, Yasaman Nader-Babaei, Habibollah Pirnejad |
| 8 |
[GO] |
2023―Aug―14 |
A meta-analysis of randomized controlled trials of statin-based therapy in patients with COVID-19 |
Guoying Kao, Yunlin Chen, Jun Xiao, Jinqi Fan |
| 9 |
[GO] |
2023―Jul―25 |
Sub-therapeutic trimethoprim and sulfamethoxazole plasma concentrations during continuous venovenous hemofiltration in a patient with COVID-19 and pulmonary Pneumocystis jirovecii co-infection: A case report |
Jos L.M.L. le Noble, Norbert Foudraine, Kim C.M. van der Elst, Sander Bouwman |
| 10 |
[GO] |
2023―Jul―25 |
Can a β-glucan-containing orthomolecular agent (Saccharomyces sp.) containing metabolic cofactors attenuate cytokine activation and alleviate hypoxia in COVID-19 patients? |
Khatuna Saganelidze, Lana Bokuchava, Ia Zedelashvili, Manana Khukhuni |
| 11 |
[GO] |
2023―Jun―08 |
Dexamethasone-induced hiccups in patients with COVID-19 |
Tomomi Yagi, Takeo Yasu, Sumi Tsubuku, Hiroyuki Jinnai, Kenta Otsuka, Shin Takahashi, Takeshi Hagino |
| 12 |
[GO] |
2023―Feb―03 |
Metformin, cancer, COVID-19, and longevity |
Karel Kostev |
| 13 |
[GO] |
2023―Jan―12 |
Evaluating real-world data in COVID-19 antigen and PCR testing |
Olaf Rose, Emina Obarcanin, Susanne Erzkamp |
| 14 |
[GO] |
2022―Nov―24 |
Comparative impact of repositioned anticancer therapies on non-cancer COVID-19 patient treatment: A systematic review and network meta-analysis of randomized controlled trials |
Ja-Young Han, Jae-Hee Kwon, Dong Hwan Kim, Heeyoung Lee |
| 15 |
[GO] |
2022―Feb―08 |
Effect of lockdown and vaccination on the course of the COVID-19 pandemic in Germany |
Peter Braun |
| 16 |
[GO] |
2022―Feb―08 |
COVID-19 pandemic management using the 14-day projected incidence |
Barry G. Woodcock |
| 17 |
[GO] |
2022―Jan―10 |
Demographic and clinical characteristics of primary care patients vaccinated against COVID-19 in spring 2021 |
Karel Kostev, Philipp Beinker, Kerstin Weber, Jens Bohlken, Christian Tanislav |
| 18 |
[GO] |
2021―Dez―02 |
COVID 19: Pandemic assessment and management using Incidencecalc(t+14) and herd immunity - Habere nos alia modum? |
Peter Braun, Barry G. Woodcock |
| 19 |
[GO] |
2021―Okt―08 |
Nocebo responses in randomized controlled trials of COVID-19 vaccines |
Young Ho Lee, Gwan Gyu Song |
| 20 |
[GO] |
2021―Aug―27 |
Tocilizumab: A retrospective multi-center cohort study of critically ill patients with COVID-19 |
Claudia R. Villatoro Santos, Ashish Bhargava, Meredith Coyle, Susan Szpunar, Louis D. Saravolatz |
| 21 |
[GO] |
2021―Jul―08 |
Increased pharmacy purchases of cardiovascular drugs from wholesalers prior to the first and second COVID-19 lockdowns |
Mark L, Sven Loosen, Marcel Konrad, Christian Tanislav, Christoph Roderburg, Karel Kostev |
| 22 |
[GO] |
2021―Jun―15 |
COVID-19 Bergamo effect and vaccination strategy |
Peter Braun |
| 23 |
[GO] |
2021―Jun―15 |
COVID-19: Effect-modelling of vaccination in Germany with regard to the mutant strain B.1.1.7 and occupancy of ICU facilities |
Peter Braun, Julian Braun, Barry G. Woodcock |
| 24 |
[GO] |
2021―Feb―24 |
Lopinavir-ritonavir alone or combined with arbidol in the treatment of 73 hospitalized patients with COVID-19: A pilot retrospective study |
Xiu Lan, Chuxiao Shao, Xu Zeng, Zhenbo Wu, Yanyan Xu |
| 25 |
[GO] |
2021―Feb―19 |
COVID-19 double whammy - Vaccine and variants |
Barry G. Woodcock |
| 26 |
[GO] |
2021―Feb―19 |
COVID-19: Predictions for SARS-CoV-2 vaccination on the course of the pandemic and critical occupancy of intensive-care facilities in Germany |
Peter Braun, Julian Braun, Barry G. Woodcock |
| 27 |
[GO] |
2020―Nov―16 |
Drug therapy strategies for COVID-19 infection during pregnancy |
Han Wang, Yu Gao, Bo Wu |
| 28 |
[GO] |
2020―Nov―03 |
COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (Primum nil nocere) |
Laura M. Sly, Peter Braun, Barry G. Woodcock |
| 29 |
[GO] |
2020―Nov―03 |
COVID-19 and the orphan biologic polyvalent immunoglobulin - “Let food be thy medication” (Hippocrates of Kos c. 460 - c. 370 BC) |
Barry G. Woodcock |
| 30 |
[GO] |
2020―Aug―17 |
COVID-19 doubling-time: Pandemic on a knife-edge |
Barry G. Woodcock |
| 31 |
[GO] |
2020―Aug―17 |
Predictions for the COVID-19 pandemic in Germany using the modified Bateman SIZ model |
Peter Braun, Steffen Haffner, Lukas Aguirre Davila, Julian Braun, Barry G. Woodcock |
| 32 |
[GO] |
2020―Jul―30 |
Prescription rates of cardiovascular and diabetes therapies prior to and during the COVID-19 lockdown in Germany |
Karel Kostev, Sachin Kumar, Marcel Konrad, Jens Bohlken |
| 33 |
[GO] |
2020―Jul―30 |
Drug evaluation and pharmaceutical care in a critically ill COVID-19 patient |
Xiang Li, Yanli Li, Shuai Guo, Wenjun Liu |
| 34 |
[GO] |
2020―Jul―10 |
COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App |
Peter Braun, Steffen Haffner, Barry G. Woodcock |
| 35 |
[GO] |
2020―Jul―10 |
The COVID-19 pandemonium continues: (Withdrawal of published clinical studies in Lancet and N Engl J Med, 2020) |
Barry G. Woodcock |
| 36 |
[GO] |
2020―Jun―09 |
Evaluation of the COVID-19 pandemic using an algorithm based on the Bateman function: Prediction of disease progression using observational data for the city of Heidelberg, Germany |
Uta Merle, Axel Laßmann, Alexander R. Dressel, Peter Braun |
| 37 |
[GO] |
2020―Jun―09 |
The COVID-19 pandemonium pandemic |
Barry G. Woodcock |
| 38 |
[GO] |
2020―Mai―25 |
COVID-19: Pentoxifylline as a potential adjuvant treatment |
Amir Feily, Kian Daneshpay, Arash Alighadr |
